List of Tables
Table 1. Global Human Coagulation Factor IV Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Coagulation Factor IV Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Coagulation Factor IV Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Coagulation Factor IV Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Human Coagulation Factor IV Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Coagulation Factor IV Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Coagulation Factor IV Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Coagulation Factor IV Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Coagulation Factor IV, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Coagulation Factor IV, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Coagulation Factor IV, Product Type & Application
Table 12. Global Key Manufacturers of Human Coagulation Factor IV, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Coagulation Factor IV by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor IV as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Coagulation Factor IV Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Coagulation Factor IV Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Human Coagulation Factor IV Sales Market Share by Region (2020-2025)
Table 19. Global Human Coagulation Factor IV Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Human Coagulation Factor IV Sales Market Share by Region (2026-2031)
Table 21. Global Human Coagulation Factor IV Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Coagulation Factor IV Revenue Market Share by Region (2020-2025)
Table 23. Global Human Coagulation Factor IV Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Coagulation Factor IV Revenue Market Share by Region (2026-2031)
Table 25. North America Human Coagulation Factor IV Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Coagulation Factor IV Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Human Coagulation Factor IV Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Human Coagulation Factor IV Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Coagulation Factor IV Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Coagulation Factor IV Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Coagulation Factor IV Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Human Coagulation Factor IV Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Human Coagulation Factor IV Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Coagulation Factor IV Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Coagulation Factor IV Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Coagulation Factor IV Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Human Coagulation Factor IV Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Human Coagulation Factor IV Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Coagulation Factor IV Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Coagulation Factor IV Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Coagulation Factor IV Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Human Coagulation Factor IV Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Human Coagulation Factor IV Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Coagulation Factor IV Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Coagulation Factor IV Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Coagulation Factor IV Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Human Coagulation Factor IV Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Human Coagulation Factor IV Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Coagulation Factor IV Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Coagulation Factor IV Sales (K Pcs) by Type (2020-2025)
Table 51. Global Human Coagulation Factor IV Sales (K Pcs) by Type (2026-2031)
Table 52. Global Human Coagulation Factor IV Sales Market Share by Type (2020-2025)
Table 53. Global Human Coagulation Factor IV Sales Market Share by Type (2026-2031)
Table 54. Global Human Coagulation Factor IV Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Coagulation Factor IV Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Coagulation Factor IV Revenue Market Share by Type (2020-2025)
Table 57. Global Human Coagulation Factor IV Revenue Market Share by Type (2026-2031)
Table 58. Global Human Coagulation Factor IV Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Human Coagulation Factor IV Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Human Coagulation Factor IV Sales (K Pcs) by Application (2020-2025)
Table 61. Global Human Coagulation Factor IV Sales (K Pcs) by Application (2026-2031)
Table 62. Global Human Coagulation Factor IV Sales Market Share by Application (2020-2025)
Table 63. Global Human Coagulation Factor IV Sales Market Share by Application (2026-2031)
Table 64. Global Human Coagulation Factor IV Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Coagulation Factor IV Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Coagulation Factor IV Revenue Market Share by Application (2020-2025)
Table 67. Global Human Coagulation Factor IV Revenue Market Share by Application (2026-2031)
Table 68. Global Human Coagulation Factor IV Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Human Coagulation Factor IV Price (USD/Pcs) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Baxter Human Coagulation Factor IV Product
Table 74. Baxter Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Bayer Human Coagulation Factor IV Product
Table 79. Bayer Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. CSL Human Coagulation Factor IV Product
Table 84. CSL Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Pfizer Human Coagulation Factor IV Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Grifols Company Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Grifols Human Coagulation Factor IV Product
Table 94. Grifols Recent Developments/Updates
Table 95. Biogen Company Information
Table 96. Biogen Description and Business Overview
Table 97. Biogen Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Biogen Human Coagulation Factor IV Product
Table 99. Biogen Recent Developments/Updates
Table 100. Octapharma Company Information
Table 101. Octapharma Description and Business Overview
Table 102. Octapharma Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Octapharma Human Coagulation Factor IV Product
Table 104. Octapharma Recent Developments/Updates
Table 105. Novo Nordisk Company Information
Table 106. Novo Nordisk Description and Business Overview
Table 107. Novo Nordisk Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Novo Nordisk Human Coagulation Factor IV Product
Table 109. Novo Nordisk Recent Developments/Updates
Table 110. Greencross Company Information
Table 111. Greencross Description and Business Overview
Table 112. Greencross Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Greencross Human Coagulation Factor IV Product
Table 114. Greencross Recent Developments/Updates
Table 115. Kedrion Company Information
Table 116. Kedrion Description and Business Overview
Table 117. Kedrion Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Kedrion Human Coagulation Factor IV Product
Table 119. Kedrion Recent Developments/Updates
Table 120. BPL Company Information
Table 121. BPL Description and Business Overview
Table 122. BPL Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. BPL Human Coagulation Factor IV Product
Table 124. BPL Recent Developments/Updates
Table 125. Hualan Bio Company Information
Table 126. Hualan Bio Description and Business Overview
Table 127. Hualan Bio Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Hualan Bio Human Coagulation Factor IV Product
Table 129. Hualan Bio Recent Developments/Updates
Table 130. RAAS Company Information
Table 131. RAAS Description and Business Overview
Table 132. RAAS Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. RAAS Human Coagulation Factor IV Product
Table 134. RAAS Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Human Coagulation Factor IV Distributors List
Table 138. Human Coagulation Factor IV Customers List
Table 139. Human Coagulation Factor IV Market Trends
Table 140. Human Coagulation Factor IV Market Drivers
Table 141. Human Coagulation Factor IV Market Challenges
Table 142. Human Coagulation Factor IV Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Coagulation Factor IV
Figure 2. Global Human Coagulation Factor IV Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Coagulation Factor IV Market Share by Type: 2024 & 2031
Figure 4. Calcium Ion Product Picture
Figure 5. Calcium Compounds Product Picture
Figure 6. Global Human Coagulation Factor IV Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Coagulation Factor IV Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Personal Clinic
Figure 10. Others
Figure 11. Global Human Coagulation Factor IV Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human Coagulation Factor IV Market Size (2020-2031) & (US$ Million)
Figure 13. Global Human Coagulation Factor IV Sales (2020-2031) & (K Pcs)
Figure 14. Global Human Coagulation Factor IV Average Price (USD/Pcs) & (2020-2031)
Figure 15. Human Coagulation Factor IV Report Years Considered
Figure 16. Human Coagulation Factor IV Sales Share by Manufacturers in 2024
Figure 17. Global Human Coagulation Factor IV Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Human Coagulation Factor IV Players: Market Share by Revenue in Human Coagulation Factor IV in 2024
Figure 19. Human Coagulation Factor IV Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Human Coagulation Factor IV Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Human Coagulation Factor IV Sales Market Share by Country (2020-2031)
Figure 22. North America Human Coagulation Factor IV Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Human Coagulation Factor IV Sales Market Share by Country (2020-2031)
Figure 26. Europe Human Coagulation Factor IV Revenue Market Share by Country (2020-2031)
Figure 27. Germany Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Human Coagulation Factor IV Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Human Coagulation Factor IV Revenue Market Share by Region (2020-2031)
Figure 34. China Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Human Coagulation Factor IV Sales Market Share by Country (2020-2031)
Figure 45. Latin America Human Coagulation Factor IV Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Human Coagulation Factor IV Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Human Coagulation Factor IV Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Human Coagulation Factor IV Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Human Coagulation Factor IV by Type (2020-2031)
Figure 55. Global Revenue Market Share of Human Coagulation Factor IV by Type (2020-2031)
Figure 56. Global Human Coagulation Factor IV Price (USD/Pcs) by Type (2020-2031)
Figure 57. Global Sales Market Share of Human Coagulation Factor IV by Application (2020-2031)
Figure 58. Global Revenue Market Share of Human Coagulation Factor IV by Application (2020-2031)
Figure 59. Global Human Coagulation Factor IV Price (USD/Pcs) by Application (2020-2031)
Figure 60. Human Coagulation Factor IV Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
